Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.56B |
| 2 |
Amazon
AMZN
|
+$1.34B |
| 3 |
Eli Lilly
LLY
|
+$1.26B |
| 4 |
NVIDIA
NVDA
|
+$1.08B |
| 5 |
Chevron
CVX
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$964M |
| 2 |
ANSS
Ansys
ANSS
|
+$924M |
| 3 |
Johnson & Johnson
JNJ
|
+$753M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$418M |
| 5 |
American Express
AXP
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.52% |
| 2 | Financials | 13.57% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 9.71% |
| 5 | Healthcare | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Koss Corp
KOSS
$34.6M
| $297K | ﹤0.01% |
58,439
+111
| +0.2% | +$628 |
|
|
CISO
3802
CISO Global
CISO
$11.8M
| $296K | ﹤0.01% |
282,346
+53,656
| +23% | +$56.6K |
|
3803
Crown Crafts
CRWS
$32M
| $294K | ﹤0.01% |
101,022
+1,782
| +2% | +$5.2K |
|
3804
Mobix Labs
MOBX
$22.3M
| $293K | ﹤0.01% |
36,348
+6,453
| +22% | +$59.3K |
|
3805
Verrica Pharmaceuticals
VRCA
$87.4M
| $292K | ﹤0.01% |
67,659
+3,043
| +5% | +$18.4K |
|
|
GGRP
3806
Glimpse Group
GGRP
$19.5M
| $290K | ﹤0.01% |
176,973
-972
| -0.5% | -$1.44K |
|
3807
Grupo Cibest SA
CIB
$22.6B
| $290K | ﹤0.01% |
5,585
-1,534
| -22% | -$74.1K |
|
|
PTHS
3808
Pelthos Therapeutics
PTHS
$100M
| $289K | ﹤0.01% |
10,330
+9,286
| +889% | +$225K |
|
3809
Verde Clean Fuels
VGAS
$27.8M
| $288K | ﹤0.01% |
94,573
+132
| +0.1% | +$402 |
|
3810
Celularity
CELU
$20M
| $288K | ﹤0.01% |
139,314
+4,489
| +3% | +$12.6K |
|
|
CCII
3811
Cohen Circle Acquisition Corp II
CCII
$358M
| $288K | ﹤0.01% |
+28,408
| New | +$287K |
|
3812
CPI Aerostructures
CVU
$72.6M
| $286K | ﹤0.01% |
113,346
| – | – |
|
|
UROY
3813
Uranium Royalty Corp
UROY
$1.56B
| $285K | ﹤0.01% |
66,178
| – | – |
|
|
RNTX
3814
Rein Therapeutics
RNTX
$68.9M
| $283K | ﹤0.01% |
247,311
+1,856
| +0.8% | +$2.36K |
|
|
SONN
3815
DELISTED
Sonnet BioTherapeutics
SONN
| $283K | ﹤0.01% |
61,840
+36,948
| +148% | +$164K |
|
|
TWNP
3816
DELISTED
Twin Hospitality Group
TWNP
| $282K | ﹤0.01% |
67,526
-483
| -0.7% | -$1.95K |
|
3817
Precipio
PRPO
$40.3M
| $281K | ﹤0.01% |
15,599
+381
| +3% | +$5.96K |
|
3818
Arqit Quantum
ARQQ
$413M
| $281K | ﹤0.01% |
7,246
| – | – |
|
3819
Dr. Reddy's Laboratories
RDY
$10.3B
| $279K | ﹤0.01% |
19,992
-1,313,564
| -99% | -$18.9M |
|
|
NIXX
3820
Nixxy Inc
NIXX
$17.8M
| $279K | ﹤0.01% |
198,005
+34,009
| +21% | +$60.8K |
|
|
AXG
3821
Solowin Holdings
AXG
$541M
| $279K | ﹤0.01% |
107,706
+59,969
| +126% | +$213K |
|
3822
Milestone Scientific
MLSS
$46.8M
| $278K | ﹤0.01% |
611,070
+60,661
| +11% | +$35.5K |
|
3823
Xilio Therapeutics
XLO
$59.5M
| $277K | ﹤0.01% |
23,498
-2,906
| -11% | -$29.1K |
|
|
INTZ
3824
Intrusion
INTZ
$15M
| $275K | ﹤0.01% |
172,064
+8,480
| +5% | +$16.1K |
|
3825
Oxbridge Re Holdings
OXBR
$9.64M
| $275K | ﹤0.01% |
153,671
+16,687
| +12% | +$34K |
|
Similar funds
Geode Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Geode Capital Management held 4,592 positions worth $1.57T, up 9.9% from $1.43T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q3 2025 filing shows 148 new, 2,907 increased, 1,130 reduced and 119 closed positions. Its largest new stake was Paramount Skydance Corp: 8,343,504 shares worth $158M. The largest sale was Hess, an estimated $964M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q3 2025 buy was Paramount Skydance Corp: 8,343,504 shares worth $158M.
- Geode Capital Management added most to Applovin in Q3 2025, an estimated $1.56B increase.
- Geode Capital Management's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $753M.
- Geode Capital Management fully exited Hess in Q3 2025, selling an estimated $964M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.57T portfolio in Q3 2025.
- Geode Capital Management opened 148 new positions and closed 119 in Q3 2025.
- Geode Capital Management's portfolio value rose 9.9% quarter-over-quarter to $1.57T.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.